🔎 Trials Near Me

Почетна › Гојазност › Северна Каролина › Wilmington

Kliničke studije za Гојазност u gradu Wilmington, NC

14 studija za Гојазност traži učesnike na lokacijama u gradu Wilmington i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Тражи се учесникФаза 3
  • Accellacare Research of Wilmington, Wilmington
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399

A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity

Тражи се учесникФаза 3
  • Accellacare - Wilmington, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07845500

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

Тражи се учесникФаза 3
  • Accellacare, Wilmington
  • Delaney Radiologist, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Тражи се учесникФаза 3
  • Trial Management Associates - Wilmington - Floral Parkway, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Тражи се учесникФаза 3
  • Accellacare - Wilmington, Wilmington
  • Jeffrey Coleman, OD, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Тражи се учесникФаза 3
  • Trial Management Associates - Wilmington - Floral Parkway, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Тражи се учесникФаза 3
  • Accellacare - Wilmington - 1917 Tradd Court, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Тражи се учесникФаза 3
  • Research Site, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Тражи се учесникФаза 2
  • Accellacare - Tradd Court - Wilmington /ID# 282200, Wilmington
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

Тражи се учесникФаза 2
  • TMA Headlands, Wilmington
Узраст од 18 до 75 · Оба пола · Ажурирано 26. 10. 2026. · NCT07837973

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Тражи се учесникФаза 1
  • Accellacare, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07607587

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Тражи се учесникФаза 3
  • Accellacare and KDCILM, LLC, Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07720271

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Тражи се учесникФаза 3
  • KDCILM, LLC & Accellacare US, Inc., Wilmington
Узраст 18 и старији · Оба пола · Ажурирано 4. 9. 2026. · NCT07745504

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Тражи се учесникФаза 3
  • ACCOMPLISH-1 Research Site, Wilmington
Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361

Studije za Гојазност u drugim gradovima

Ostale studije u gradu Wilmington

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.